Christian Hordo
Corporate Officer/Principal bij SANA BIOTECHNOLOGY, INC.
Vermogen: 7 M $ op 30-04-2024
Actieve functies van Christian Hordo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01-10-2018 | - |
Loopbaan van Christian Hordo
Eerdere bekende functies van Christian Hordo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01-03-2015 | 01-10-2018 |
Opleiding van Christian Hordo
| Harvard Business School | Masters Business Admin |
| University of Toronto | Graduate Degree |
| McGill University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Canada | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Graduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Beurs
- Insiders
- Christian Hordo
- Ervaring
